Angiogenesis PET Tracer Uptake (68Ga-NODAGA-E[(cRGDyK)]₂) in Induced Myocardial Infarction and Stromal Cell Treatment in Minipigs.
Thomas RasmussenBjarke FollinJens KastrupMalene Brandt-LarsenJacob MadsenThomas Emil ChristensenMorten JuhlSmadar CohenKarsten Pharao HammelevChristian Holdflod MøllerJens Peter GoetzePhilip HasbakAndreas KjærPublished in: Diagnostics (Basel, Switzerland) (2018)
Angiogenesis is considered integral to the reparative process after ischemic injury. The αvβ₃ integrin is a critical modulator of angiogenesis and highly expressed in activated endothelial cells. 68Ga-NODAGA-E[(cRGDyK)]₂ (RGD) is a positron-emission-tomography (PET) ligand targeted towards αvβ₃ integrin. The aim was to present data for the uptake of RGD and correlate it with histology and to further illustrate the differences in angiogenesis due to porcine adipose-derived mesenchymal stromal cell (pASC) or saline treatment in minipigs after induction of myocardial infarction (MI). Three minipigs were treated with direct intra-myocardial injection of pASCs and two minipigs with saline. MI was confirmed by 82Rubidium (82Rb) dipyridamole stress PET. Mean Standardized Uptake Values (SUVmean) of RGD were higher in the infarct compared to non-infarct area one week and one month after MI in both pASC-treated (SUVmean: 1.23 vs. 0.88 and 1.02 vs. 0.86, p < 0.05 for both) and non-pASC-treated minipigs (SUVmean: 1.44 vs. 1.07 and 1.26 vs. 1.04, p < 0.05 for both). However, there was no difference in RGD uptake, ejection fractions, coronary flow reserves or capillary density in histology between the two groups. In summary, indications of angiogenesis were present in the infarcted myocardium. However, no differences between pASC-treated and non-pASC-treated minipigs could be demonstrated.
Keyphrases
- positron emission tomography
- endothelial cells
- pet ct
- computed tomography
- high glucose
- vascular endothelial growth factor
- pet imaging
- bone marrow
- heart failure
- left ventricular
- acute myocardial infarction
- wound healing
- coronary artery
- stem cells
- cell therapy
- coronary artery disease
- randomized controlled trial
- electronic health record
- combination therapy
- drug delivery
- mesenchymal stem cells
- atrial fibrillation
- heat stress
- percutaneous coronary intervention
- aortic valve
- data analysis